A detailed history of Strs Ohio transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Strs Ohio holds 16,569 shares of NBIX stock, worth $2.08 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
16,569
Previous 21,062 21.33%
Holding current value
$2.08 Million
Previous $2.9 Million 34.22%
% of portfolio
0.01%
Previous 0.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$114.58 - $153.15 $514,807 - $688,102
-4,493 Reduced 21.33%
16,569 $1.91 Million
Q2 2024

Aug 05, 2024

BUY
$130.86 - $143.19 $634,409 - $694,185
4,848 Added 29.9%
21,062 $2.9 Million
Q1 2024

May 13, 2024

BUY
$130.4 - $143.74 $176,952 - $195,055
1,357 Added 9.13%
16,214 $2.24 Million
Q4 2023

Jan 30, 2024

BUY
$106.07 - $132.76 $1.58 Million - $1.97 Million
14,857 New
14,857 $1.96 Million
Q2 2023

Jul 31, 2023

SELL
$89.53 - $104.87 $163,660 - $191,702
-1,828 Reduced 9.54%
17,341 $1.64 Million
Q1 2023

Aug 02, 2023

BUY
$94.11 - $123.02 $172,033 - $224,880
1,828 Added 10.54%
19,169 $1.94 Million
Q1 2023

Apr 27, 2023

BUY
$94.11 - $123.02 $286,282 - $374,226
3,042 Added 18.86%
19,169 $1.94 Million
Q4 2022

Jan 26, 2023

BUY
$106.72 - $127.06 $325,175 - $387,151
3,047 Added 23.3%
16,127 $1.93 Million
Q3 2022

Oct 27, 2022

BUY
$92.03 - $107.81 $19,510 - $22,855
212 Added 1.65%
13,080 $1.39 Million
Q2 2022

Jul 25, 2022

BUY
$75.79 - $100.07 $900,233 - $1.19 Million
11,878 Added 1199.8%
12,868 $1.25 Million
Q2 2021

Jul 26, 2021

SELL
$89.43 - $102.27 $735,472 - $841,068
-8,224 Reduced 89.26%
990 $96,000
Q1 2021

Apr 23, 2021

SELL
$87.57 - $119.4 $1.17 Million - $1.59 Million
-13,343 Reduced 59.15%
9,214 $896,000
Q4 2020

Jan 25, 2021

SELL
$86.91 - $108.33 $74,221 - $92,513
-854 Reduced 3.65%
22,557 $2.16 Million
Q3 2020

Dec 14, 2020

SELL
$96.16 - $135.15 $115,968 - $162,990
-1,206 Reduced 4.9%
23,411 $2.25 Million
Q2 2020

Jul 23, 2020

BUY
$85.09 - $130.36 $1.45 Million - $2.22 Million
17,038 Added 224.81%
24,617 $3 Million
Q1 2020

Apr 23, 2020

BUY
$75.11 - $113.76 $127,236 - $192,709
1,694 Added 28.79%
7,579 $655,000
Q4 2019

Jan 24, 2020

BUY
$86.8 - $118.57 $510,818 - $697,784
5,885 New
5,885 $632,000
Q3 2019

Oct 21, 2019

SELL
$83.82 - $101.5 $0 - $0
0 Closed
0 $0
Q2 2019

Jul 25, 2019

SELL
$72.24 - $91.27 $130,609 - $165,016
-1,808 Closed
0 $0
Q1 2019

Apr 19, 2019

SELL
$69.31 - $91.53 $59,537 - $78,624
-859 Reduced 32.21%
1,808 $159,000
Q4 2018

Jan 23, 2019

BUY
$68.32 - $124.36 $44,134 - $80,336
646 Added 31.96%
2,667 $190,000
Q3 2018

Oct 19, 2018

SELL
$98.88 - $125.85 $16,315 - $20,765
-165 Reduced 7.55%
2,021 $248,000
Q2 2018

Aug 06, 2018

BUY
$75.3 - $105.99 $164,605 - $231,694
2,186 New
2,186 $214,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.